Literature DB >> 28761949

Immune Checkpoint Inhibitor Therapy in a Liver Transplant Recipient With Melanoma.

Gustavo Schvartsman1, Kristen Perez1, Gagan Sood1, Riham Katkhuda1, Hussein Tawbi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28761949     DOI： 10.7326/L17-0187

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  11 in total

Review 1.  Liver graft rejection following immune checkpoint inhibitors treatment: a review.

Authors:  Bo Hu; Xiao-Bo Yang; Xin-Ting Sang
Journal:  Med Oncol       Date:  2019-10-11       Impact factor: 3.064

Review 2.  An analysis report on the application of immune checkpoint inhibitors after liver transplantation.

Authors:  Man Xie; Zhi-Ping Dang; Xue-Guo Sun; Bei Zhang; Qun Zhang; Qiu-Ju Tian; Jin-Zhen Cai; Wei Rao
Journal:  Ther Adv Chronic Dis       Date:  2022-05-19       Impact factor: 4.970

Review 3.  Cutaneous squamous cell carcinoma in the organ transplant recipient.

Authors:  Kristin Bibee; Andrew Swartz; Shaum Sridharan; Cornelius H L Kurten; Charles B Wessel; Heath Skinner; Dan P Zandberg
Journal:  Oral Oncol       Date:  2020-02-14       Impact factor: 5.337

4.  Application of Immune Checkpoint Inhibitors in Solid Organ Transplantation Recipients: A Systematic Review.

Authors:  Kang Miao; Li Zhang
Journal:  Interdiscip Sci       Date:  2021-06-21       Impact factor: 2.233

5.  The Safety and Efficacy of Checkpoint Inhibitors in Transplant Recipients: A Case Series and Systematic Review of Literature.

Authors:  Vivek Kumar; Atul B Shinagare; Helmut G Rennke; Sandeep Ghai; Jochen H Lorch; Patrick A Ott; Osama E Rahma
Journal:  Oncologist       Date:  2020-02-11

6.  Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature.

Authors:  Noha Abdel-Wahab; Houssein Safa; Ala Abudayyeh; Daniel H Johnson; Van Anh Trinh; Chrystia M Zobniw; Heather Lin; Michael K Wong; Maen Abdelrahim; A Osama Gaber; Maria E Suarez-Almazor; Adi Diab
Journal:  J Immunother Cancer       Date:  2019-04-16       Impact factor: 13.751

7.  Systematic Review of the Safety of Immune Checkpoint Inhibitors Among Kidney Transplant Patients.

Authors:  Sandhya Manohar; Charat Thongprayoon; Wisit Cheungpasitporn; Svetomir N Markovic; Sandra M Herrmann
Journal:  Kidney Int Rep       Date:  2019-12-07

8.  Pilot evaluation of PD-1 inhibition in metastatic cancer patients with a history of liver transplantation: the Mayo Clinic experience.

Authors:  Thomas T DeLeon; Marcela A Salomao; Bashar A Aqel; Mohamad B Sonbol; Raquel T Yokoda; Ahmad H Ali; Adyr A Moss; Amit K Mathur; David M Chascsa; Jorge Rakela; Alan H Bryce; Mitesh J Borad
Journal:  J Gastrointest Oncol       Date:  2018-12

9.  Liver Allograft Failure After Nivolumab Treatment-A Case Report With Systematic Literature Research.

Authors:  Dimitri Gassmann; Stefan Weiler; Joachim C Mertens; Cäcilia S Reiner; Bart Vrugt; Mirjam Nägeli; Joanna Mangana; Beat Müllhaupt; Fabienne Jenni; Benjamin Misselwitz
Journal:  Transplant Direct       Date:  2018-07-20

Review 10.  Immunotherapy in liver transplantation for hepatocellular carcinoma: Pros and cons.

Authors:  Yi Luo; Fei Teng; Hong Fu; Guo-Shan Ding
Journal:  World J Gastrointest Oncol       Date:  2022-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.